Color Code
Brown

Partnership Fund for HPV Genotyping

889
Infectious Disease
Partnership Fund for HPV Genotyping
United States of America
To provide technical and analytical expertise in HPV genotyping and immune response measurements to academic and other partners in need of these assays to advance public health objectives related to HPV vaccine impact monitoring and HPV epidemiology.
ViroStat, Inc.; Quebec Public Health Institute
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Microbicide Intrauterine System for HIV Prevention

899
Woman
Microbicide Intrauterine System for HIV Prevention
Virginia, USA
United States of America
To perform preclinical research targeted towards HIV prevention in women.
CONRAD (Eastern Virginia Medical School)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

Opt-Out Chlamydia Screening Effectiveness

894
holding hands
Opt-Out Chlamydia Screening Effectiveness
United States of America
To explore the effectiveness of opt-out chlamydia screening via electronic health record prompt and to increase the percentage of women under the age of 25 who are screened for chlamydia at clinical encounters.
Hologic, Inc.
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; University of Pittsburgh

Integrated Rotavirus Vaccine Development Plan

877
Low income countries
Integrated Rotavirus Vaccine Development Plan
United States of America
To implement a robust product development program for an integrated inactivated rotavirus vaccine in low-income countries.
Bill & Melinda Gates Foundation
CDC's National Center for Immunization and Respiratory Diseases

Making Dialysis Safer for Patients

882
Map
Making Dialysis Safer for Patients
United States of America
To reduce potentially deadly bloodstream infections in hemodialysis outpatients by targeting patients, healthcare providers and caregivers using evidence-based communications strategies with prevention messages.
Amgen
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Evaluation of Rabies Virus Vectored Ebola Vaccine

907
Ebola
Evaluation of Rabies Virus Vectored Ebola Vaccine
Pennsylvania, USA
United States of America
To design and evaluate a thermostable Rabies Virus Vectored Ebola Vaccine. As Ebola exists in some of the poorest parts of the world where the climate is tropical, the development of a thermostable vaccine could be cost-effective, resulting in greater long-term vaccine stability in high ambient temperatures.
Thomas Jefferson University (National Institutes of Health)
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Study of Dapivirine Gel Administered Rectally

911
holding hands
Study of Dapivirine Gel Administered Rectally
Thailand
To study the effectiveness of dapivirine gel exposure intended to prevent HIV transmission.
Magee-Womens Research Institute and Foundation (National Institutes of Health/National Institute of Allergy and Infectious Disease)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of HIV/AIDS Prevention; Thailand Ministry of Public Health

Combination HIV Prevention Intervention in Thailand

914
thailand
Combination HIV Prevention Intervention in Thailan
Thailand
To conduct a study to assess the feasibility of a combination HIV preventive intervention with and without daily Truvada PrEP for HIV uninfected young men who have sex with men in Bangkok, Thailand.
Johns Hopkins University (National Institutes of Health/National Institute of Allergy and Infectious Disease)
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV/AIDS Prevention; Thailand Ministry of Public Health
Subscribe to Infectious Disease